Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Combined Neuromodulation Therapy to Enhance Balance and Neuroplasticity After Incomplete SCI

NCT05940636 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT05940636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05940636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Combined Neuromodulation Therapy to Enhance Balance and Neuroplasticity After Incomplete SCI
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Completed
Start date
November 5, 2023
Completion date
January 30, 2026
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fall, muscle pareses, spinal cord injuries